N1 non-small-cell lung cancer. A 20-year surgical experience

Asian Cardiovascular and Thoracic Annals

Volumn 19, Issue 3-4, 2011, Pages 217-224

  Casali, Christian ^a   Stefani, Alessandro ^a   Morandi, Uliano ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Lymphatic metastasis; Neoplasm staging; Non small cell lung carcinoma; Pneumonectomy; Thoracic surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 80054788446     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492311407904     Document Type: Article

References (20)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717. (Pubitemid 27260107)
2. Rusch VW, Crowley J, Giroux DJ, Goldstraw P, Im JG, Tsuboi M, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2: 603-612. (Pubitemid 47171781)
3. Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D and Stamatis G. Pathologic N1 nonsmall cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 2003; 125: 543-553. (Pubitemid 36373900)
4. Nakagawa T, Okumura N, Kokado Y, Miyoshi K, Matsuoka T and Kameyama K. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2007; 6: 474-478. (Pubitemid 47403940)
5. Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW and Kim JH. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Ann Thorac Surg 2008; 86: 1092-1097.
6. Matsuoka K, Sumitomo S and Misaki N. Prognostic factors in patients with pathologic T1-21M0 disease in non-small cell carcinoma of the lung. J Thorac Oncol 2007; 2: 1098-1102. (Pubitemid 350307902)
7. Cerfolio RJ and Bryant AS. Predictors of survival and disease-free survival in patients with resected N1 nonsmall cell lung cancer. Ann Thorac Surg 2007; 84: 182-190. (Pubitemid 46921142)
8. Fujimoto T, Cassivi SD, Yang P, Barnes SA, Nichols FC, Deschamps C, et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and longterm survival. J Thorac Cardiovasc Surg 2006; 132: 499-506. (Pubitemid 44278877)
9. Mountain CF and Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-1723. (Pubitemid 27260108)
10. The Japan Lung Cancer Society. Classification of Lung Cancer, 1st English ed. Tokyo: Kanehara & Co, 2000.
11. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P, et al. The IASLC Lung Cancer Staging Project: a proposal for a new international lymph node map in the forthcoming 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4: 568-577.
12. Demir A, Turna A, Kocaturk C, Gunluoglu MZ, Aydogmus U, Urer N, et al. Prognostic significance of surgical-pathologic N1 lymph node involvement in nonsmall cell lung cancer. Ann Thorac Surg 2009; 87: 1014-1022.
13. Lee JG, Lee CY, Bae MK, Park IK, Kim DJ, Kim KD, et al. Validity of international association for the study of lung cancer proposals for the revision of the N descriptors in lung cancer. J Thoracic Oncol 2008; 3: 1421-1426.
14. Scott WJ, Howington J, Feigenberg S, Movsas B and Pisters K. American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 234S-42S. (Pubitemid 47502810)
15. Aydogmus U, Cansever L, Sonmezoglu Y, Karapinar K, Kocaturk CI and Bedirhan MA. The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers. Eur J Cardiothorac Surg 2010; 37: 446-450.
16. Kim YT, Kang CH, Sung SW and Kim JH. Local control of disease related to lymph node involvement in nonsmall cell lung cancer after sleeve lobectomy compared with pneumonectomy. Ann Thorac Surg 2005; 79: 1153-11561.
17. Khan OA, Fitzgerald JJ, Field ML, Soomro I, Beggs FD, Morgan WE, et al. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung. Ann Thorac Surg 2004; 77: 1173-1178. (Pubitemid 38452341)
18. Luzzi L, Voltolini L, Campione A, Paladini P, Ghiribelli C, Di Bisceglie M, et al. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival? J Cardiovasc Surg (Torino) 2003; 44: 119-123. (Pubitemid 36527380)
19. Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M, et al. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer 2004; 45: 215-220. (Pubitemid 38891484)
20. Casali C, Stefani A, Natali P, Rossi G and Morandi U. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of lymph nodes metastases. Eur J Cardiothoracic Surg 2005; 28: 33-38. (Pubitemid 40883928)